Welcome to LookChem.com Sign In|Join Free

CAS

  • or

308108-11-4

308108-11-4

Post Buying Request

308108-11-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

308108-11-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 308108-11-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,8,1,0 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 308108-11:
(8*3)+(7*0)+(6*8)+(5*1)+(4*0)+(3*8)+(2*1)+(1*1)=104
104 % 10 = 4
So 308108-11-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O2/c13-8-9-3-1-4-10(7-9)14-6-2-5-11(14)12(15)16/h1,3-4,7,11H,2,5-6H2,(H,15,16)/t11-/m0/s1

308108-11-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-1-(3-cyanophenyl)pyrrolidine-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names L-Proline,1-(3-cyanophenyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:308108-11-4 SDS

308108-11-4Relevant articles and documents

AMIDINOANILINE DERIVATIVE

-

Paragraph 0176-0179; 0212-0214, (2013/03/26)

Provided are a novel amidine derivative having an activated blood coagulation factor X inhibitory activity, a production method thereof, a production intermediate therefor, and a pharmaceutical composition containing the amidine derivative. An amidinoanil

Cyclic amino acid derivatives

-

, (2008/06/13)

Novel compounds of the formula I 1in which R1, R2, R2′, R2″, R3, R4, R5, R5′, R5″, R5′″, R5″″, X, Y, U, V and W are as defined in Patent claim 1, are inhibitors of coagulation factors Xa and VIIa and can be employed fr the treatment of thromboses, myocardilal infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 308108-11-4